Jefferies assumes coverage on Indivior stock with Buy rating on reset expectations

Jefferies has initiated coverage on Indivior (INDV) with a Buy rating and a $20 price target, citing the stock's undervaluation and a positive reset of expectations after a challenging 2024. The firm anticipates a return to growth for Indivior's Sublocade product as competitive dynamics stabilize and past challenges are understood, projecting higher 2027 EPS of $2.42 against a consensus of $1.84 due to expected lower operational expenses. This bullish outlook is reinforced by recent strategic corporate developments, including key leadership appointments and the company's transition to a primary Nasdaq listing.

Analysis

Jefferies has initiated coverage on Indivior (INDV) with a Buy rating and a $20.00 price target, presenting a bullish case for a stock already trading near its 52-week high after a 47.73% one-year return. The core of the thesis rests on the belief that market expectations have been reset following a difficult 2024, with most negative factors now priced into the stock. Jefferies highlights that the competitive pressure on Indivior’s key Sublocade product from its rival Brixadi has largely stabilized and that challenges related to the Criminal Justice System are now well understood, setting the stage for a return to growth. This view is supported by a significantly above-consensus earnings forecast, with Jefferies projecting a 2027 EPS of $2.42 versus the market's $1.84, driven by an expectation for lower future operational expenses. This analyst upgrade coincides with significant corporate restructuring at Indivior, including the appointment of a new CEO and Chief Commercial Officer, and a strategic shift of its primary listing from the London Stock Exchange to Nasdaq, signaling a clear intent to strengthen governance and enhance its market position.

Key Decisions for Investors

• Given the new Buy rating, a price target suggesting notable upside, and a contrarian earnings forecast from Jefferies, investors could view this as a catalyst for re-evaluating Indivior's growth prospects.
• Investors should closely monitor future earnings reports for validation of Jefferies' thesis, specifically looking for evidence of Sublocade's return to growth and confirmation of lower-than-consensus operational expenditures.
• The recent management overhaul and the primary listing move to Nasdaq are significant strategic shifts; long-term investors should assess whether this new leadership and market focus can effectively execute on the commercial strategy and unlock further value.